Latest Fluticasone/salmeterol Stories
QXFORD, England, September 2, 2014 /PRNewswire/ -- Triggers milestone payment from Mylan Prosonix, an innovative speciality pharmaceutical
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
The GlaxoSmithKline settlement involves the District of Columbia and 44 states over the marketing of Advair, Paxil, and Wellbutrin. Port Washington, NY (PRWEB)
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, May 19, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) today presented data at the American Thoracic Society (ATS) from a late-stage clinical study.
OXFORD, England, May 15, 2014 /PRNewswire/ -- First full presentation of data from randomised clinical study of glycopyrronium bromide made using
OXFORD, England and PITTSBURGH, April 15, 2014 /PRNewswire/ -- Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design,
LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
Asthma Drugs Face More Scrutiny in Insurance Exchanges, According to Findings from Decision Resources Group BURLINGTON, Mass., March 5, 2014 /PRNewswire/ -- Decision Resources Group finds that
- Emitting flashes of light; glittering.